
Join to View Full Profile
395 W 12th AveColumbus, OH 43210
Dr. Prasath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vishnu Prasath is an Internal Medicine resident physician at The Ohio State University Wexner Medical Center in Columbus, OH, beginning in 2023. He earned his medical degree from Rutgers New Jersey Medical School in 2023 and holds both bachelor's and master's honors degrees in Biomedical Engineering from Johns Hopkins University. Dr. Prasath is an active researcher with publications in areas such as breast cancer treatment, cost-effectiveness in cancer management, and cancer epidemiology. His work has been published in journals including Breast Cancer Research and Treatment, Current Problems in Surgery, and Cancer Epidemiology.
Education & Training
- Rutgers New Jersey Medical SchoolClass of 2023
- Johns Hopkins UniversityMS, Applied Biomedical Engineering, Honors, 2017 - 2019
- Johns Hopkins UniversityBS, Biomedical Engineering, Honors, 2013 - 2017
Certifications & Licensure
- OH State Medical License 2025 - 2027
Publications & Presentations
PubMed
- Redefining the Role of Hemicorporectomy in the Modern Era and Shifting Trends Toward Non-Malignant Indications.Joshua D Greendyk, Syed F Haider, William E Allen, Vishnu Prasath, Ravi J Chokshi
The American Surgeon. 2025-09-01 - HSR25-154: Treatment Patterns and Prognosis of Patients With HER2-Negative Early Breast Cancer and Germline Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2.Vishnu Prasath, Andrea Riner, Joanne Kim, Akia Clark, Brandon Slover
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 4 citationsPhase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers
Breast Cancer Research and Treatment. 2025-02-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: